158 related articles for article (PubMed ID: 24349055)
21. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
[TBL] [Abstract][Full Text] [Related]
22. Abelson murine leukemia virus transforms preneoplastic Emu-myc transgene-carrying cells of the B-lymphocyte lineage into plasmablastic tumors.
Sugiyama H; Silva S; Wang YS; Weber G; Babonits M; Rosén A; Wiener F; Klein G
Int J Cancer; 1990 Nov; 46(5):845-52. PubMed ID: 2228313
[TBL] [Abstract][Full Text] [Related]
23. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.
Yu D; Allman D; Goldschmidt MH; Atchison ML; Monroe JG; Thomas-Tikhonenko A
Blood; 2003 Mar; 101(5):1950-5. PubMed ID: 12406913
[TBL] [Abstract][Full Text] [Related]
24. Rapid viral induction of murine lymphomas in the graft-versus-host reaction.
Cornelius EA
J Exp Med; 1972 Dec; 136(6):1533-44. PubMed ID: 4404880
[TBL] [Abstract][Full Text] [Related]
25. The natural history of a novel, systemic, disseminated model of syngeneic mouse B-cell lymphoma.
Passineau MJ; Siegal GP; Everts M; Pereboev A; Jhala D; Wang M; Zhu ZB; Park SK; Curiel DT; Nelson GM
Leuk Lymphoma; 2005 Nov; 46(11):1627-1638. PubMed ID: 16334907
[TBL] [Abstract][Full Text] [Related]
26. T cell-induced Ig allotypic suppression in mice. II. Both CD4+ CD8- and CD4- CD8+ T cell subsets from sensitized Igha mice are required to induce suppression of Igh-1b allotype expression.
Benaroch P; Bordenave G
J Immunol; 1989 Jan; 142(1):1-7. PubMed ID: 2521230
[TBL] [Abstract][Full Text] [Related]
27. In vivo therapeutic effects of interleukin-12 against highly metastatic residual lymphoma.
Verbik DJ; Stinson WW; Brunda MJ; Kessinger A; Joshi SS
Clin Exp Metastasis; 1996 May; 14(3):219-29. PubMed ID: 8674276
[TBL] [Abstract][Full Text] [Related]
28. The immunoglobulin heavy chain gene 3' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells.
Xiang H; Noonan EJ; Wang J; Duan H; Ma L; Michie S; Boxer LM
Leukemia; 2011 Sep; 25(9):1484-93. PubMed ID: 21606958
[TBL] [Abstract][Full Text] [Related]
29. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
Strasser A; Harris AW; Bath ML; Cory S
Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
[TBL] [Abstract][Full Text] [Related]
30. In vivo bioluminescence imaging of tumor hypoxia dynamics of breast cancer brain metastasis in a mouse model.
Saha D; Dunn H; Zhou H; Harada H; Hiraoka M; Mason RP; Zhao D
J Vis Exp; 2011 Oct; (56):. PubMed ID: 21989061
[TBL] [Abstract][Full Text] [Related]
31. The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype.
Truffinet V; Pinaud E; Cogné N; Petit B; Guglielmi L; Cogné M; Denizot Y
J Immunol; 2007 Nov; 179(9):6033-42. PubMed ID: 17947677
[TBL] [Abstract][Full Text] [Related]
32. A Dual-Color Bioluminescence Reporter Mouse for Simultaneous
Kleinovink JW; Mezzanotte L; Zambito G; Fransen MF; Cruz LJ; Verbeek JS; Chan A; Ossendorp F; Löwik C
Front Immunol; 2018; 9():3097. PubMed ID: 30671062
[TBL] [Abstract][Full Text] [Related]
33. Fidelity and infidelity in commitment to B-lymphocyte lineage development.
Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F
Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595
[TBL] [Abstract][Full Text] [Related]
34. A murine model for B-cell lymphomagenesis in immunocompromised hosts: c-myc-rearranged B-cell lines with a premalignant phenotype.
Felsher DW; Denis KA; Weiss D; Ando DT; Braun J
Cancer Res; 1990 Nov; 50(21):7042-9. PubMed ID: 2208171
[TBL] [Abstract][Full Text] [Related]
35. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
[No Abstract] [Full Text] [Related]
36. Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation.
Tormo A; Khodayarian F; Cui Y; Al-Chami E; Kanjarawi R; Noé B; Wang H; Rafei M
J Hematol Oncol; 2017 Jun; 10(1):120. PubMed ID: 28615039
[TBL] [Abstract][Full Text] [Related]
37. NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.
Han SS; Yun H; Son DJ; Tompkins VS; Peng L; Chung ST; Kim JS; Park ES; Janz S
Mol Cancer; 2010 Apr; 9():97. PubMed ID: 20433747
[TBL] [Abstract][Full Text] [Related]
38. Myeloid, B and T lymphoid and mixed lineage thymic lymphomas in the irradiated mouse.
Boulton E; Cleary H; Plumb M
Carcinogenesis; 2002 Jun; 23(6):1079-85. PubMed ID: 12082032
[TBL] [Abstract][Full Text] [Related]
39. The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.
Harris AW; Pinkert CA; Crawford M; Langdon WY; Brinster RL; Adams JM
J Exp Med; 1988 Feb; 167(2):353-71. PubMed ID: 3258007
[TBL] [Abstract][Full Text] [Related]
40. A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis.
Berg T; Thoene S; Yap D; Wee T; Schoeler N; Rosten P; Lim E; Bilenky M; Mungall AJ; Oellerich T; Lee S; Lai CK; Umlandt P; Salmi A; Chang H; Yue L; Lai D; Cheng SW; Morin RD; Hirst M; Serve H; Marra MA; Morin GB; Gascoyne RD; Aparicio SA; Humphries RK
Blood; 2014 Jun; 123(25):3914-24. PubMed ID: 24802772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
